Patrick D. Spangler

This profile gathers the share dealings of Patrick D. Spangler across 3 companies, led by OptimizeRx Corp, ev3 Inc. and Urologix Inc. Between 22 January 2007 and 28 August 2025, the trades on record add up to 41 filings.

On the open market, the record shows 3 purchases worth €817 and 13 sales worth €652k. The totals exclude 2 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 20 share grants and 5 option exercises. In 2025 alone, the filings show no purchases and 1 sale.

The latest filing, published on 11 September 2025, reports an open-market sale of €166k in OptimizeRx Corp. The last insider purchase was made public on 10 October 2018, 2,936 days ago. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.